By Milton Packer, MD
Most observers do not understand what the academic leaders of a clinical trial really do. To many, the steering committee simply takes its marching orders from industry sponsors. Some believe that every trial is designed by … Read more
Most women dread turning 40, not me. The morning of February 9th, 2017, I hopped out of bed and headed off to teach my weekly cycling class. Health and fitness are two of my passions. I’ve been a group fitness … Read more
A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types.
In patients with advanced, drug-resistant cancers, over a quarter with cervical and … Read more
By Michael Murray
There are diseases and health conditions that are essentially invisible to us until it is too late.
When those problems are life-threatening, such as cancer, and if there is a period when something could be done, then … Read more
A recent study conducted at Denmark’s Vejle Hospital, published in Pharmacological Research, provides evidence of delta-tocotrienol’s benefits for cancer patients. Results of the open-label trial suggest that American River Nutrition-manufactured delta-tocotrienol in combination with bevacizumab had additive effects in chemotherapy … Read more
Xconomy San Diego — Last week, it was reported by multiple media outlets (see here, and here, and here) that a group of Israeli scientists had found “a cure for all cancer” and that … Read more
Women may not need to undergo surgery for non-cancerous ovarian cysts, avoiding potential surgical complications.
This is the finding of new research, by a team of international scientists from institutions including Imperial College London and KU Leuven, published in The … Read more
Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare … Read more
By Kristi Rosa
Data from a retrospective study suggests an adjuvant gastrointestinal (GI)-based chemotherapy regimen is more beneficial than one that is gynecologic-based in patients with mucinous ovarian cancer, said Katherine C. Kurnit, MD.
“Right now, mucinous ovarian cancer is … Read more
This beautifully written piece sheds light on the struggles that caregivers on the cancer journey face after losing their loved one. Caregivers are critical sources of support throughout someone’s cancer journey, but their true strength shines through with how they … Read more
By Anubhuti Matta
Nine months — that’s how long Shradha Gupta, 51, waited for an ovarian cancer diagnosis.
“I had a terrible pain in the pelvic region, felt bloated all the time, but the gynecologist kept asking me to wait … Read more
By Barbara Tako
Cancerland is a frightening place to be for days, weeks, months and yes, even years. Turn that worry into something positive; reach out and be kind today and every day forward.
Before cancer survivorship, I know I … Read more
“There’s that element of anxiety and stress and not necessarily having an educational resource to turn to.”
Over The Counter
23andMe is already allowed to screen customers for mutations associated with an increased risk of breast cancer. … Read more
By Kelly Irvin
Rather than revisiting the ghosts of cancer treatments past, I’m focused on using what I’ve learned in three years of active treatment and maintenance for incurable, metastatic cancer.
My three-year cancerversary is quickly approaching. On Jan. 13, … Read more
Immune cells called macrophages are supposed to serve and protect, but cancer has found ways to put them to sleep. Now researchers at the Abramson Cancer Center of the University of Pennsylvania say they’ve identified how to fuel macrophages with … Read more
By Jessica Skarzynski
For some time now, paclitaxel has been considered standard of care in the treatment of patients with platinum-resistant ovarian cancer; however, recent research has shown the addition of the investigational drug alisertib to a paclitaxel regimen demonstrated … Read more
Researchers at The Institute of Cancer Research, London (ICR) have developed an artificial intelligence (AI) test that analyses the shape of tumour cells to identify patients with aggressive ovarian cancer.
The test is intended to enable tailored treatment based on … Read more
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.
